Yan F - Search Results

1

MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.

Yan G, Ru Y, Yan F, Xiong X, Hu W, Pan T, Sun J, Zhang C, Wang Q, Li X. Yan G, et al. Among authors: yan f. Cell Commun Signal. 2019 May 15;17(1):44. doi: 10.1186/s12964-019-0355-1. Cell Commun Signal. 2019. PMID: 31092266 Free PMC article.

2

Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy.

Yan F, Li X, Li N, Zhang R, Wang Q, Ru Y, Hao X, Ni J, Wang H, Wu G. Yan F, et al. Cancer Lett. 2017 Aug 28;402:32-42. doi: 10.1016/j.canlet.2017.05.003. Epub 2017 May 19. Cancer Lett. 2017. PMID: 28529067

3

GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.

Yan G, Ru Y, Wu K, Yan F, Wang Q, Wang J, Pan T, Zhang M, Han H, Li X, Zou L. Yan G, et al. Among authors: yan f. Prostate. 2018 Feb;78(3):166-177. doi: 10.1002/pros.23461. Epub 2017 Nov 27. Prostate. 2018. PMID: 29181846

4

IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.

Zhang Y, Lv W, Li Q, Wang Q, Ru Y, Xiong X, Yan F, Pan T, Lin W, Li X. Zhang Y, et al. Among authors: yan f. Mol Med Rep. 2019 Aug;20(2):1893-1900. doi: 10.3892/mmr.2019.10418. Epub 2019 Jun 24. Mol Med Rep. 2019. PMID: 31257503

5

Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.

Yan G, Ru Y, Yan F, Xiong X, Hu W, Pan T, Sun J, Zhang C, Wang Q, Li X. Yan G, et al. Among authors: yan f. Cell Commun Signal. 2019 Oct 21;17(1):130. doi: 10.1186/s12964-019-0441-4. Cell Commun Signal. 2019. PMID: 31639006 Free PMC article.

6

MIIP inhibits EMT and cell invasion in prostate cancer through miR-181a/b-5p-KLF17 axis.

Hu W, Yan F, Ru Y, Xia M, Yan G, Zhang M, Wang H, Wu G, Yao L, Shen L, Li X, Wang Q. Hu W, et al. Among authors: yan f, yan g. Am J Cancer Res. 2020 Feb 1;10(2):630-647. eCollection 2020. Am J Cancer Res. 2020. PMID: 32195032 Free PMC article.

7

MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis.

Yan F, Wang Q, Xia M, Ru Y, Hu W, Yan G, Xiong X, Zhang M, Wang J, Li Q, Zhang B, Wang H, Lin W, Wu G, Li X. Yan F, et al. Among authors: yan g. Cancer Biol Med. 2021 Dec 22;19(6):818-35. doi: 10.20892/j.issn.2095-3941.2020.0296. Cancer Biol Med. 2021. PMID: 34931765 Free PMC article.

8

Loss of Sfrp2 contributes to the neurological disorders related with morphine withdrawal via Wnt/β-catenin signaling.

Wang JC, Li YQ, Feng DY, Zhou X, Yan FQ, Li Y, Gao L, Li LH. Wang JC, et al. Behav Brain Res. 2019 Feb 1;359:609-618. doi: 10.1016/j.bbr.2018.10.005. Epub 2018 Oct 3. Behav Brain Res. 2019. PMID: 30291843

9

GSK-3β Inhibitor Alsterpaullone Attenuates MPP⁺-Induced Cell Damage in a c-Myc-Dependent Manner in SH-SY5Y Cells.

Wang J, Li Y, Gao L, Yan F, Gao G, Li L. Wang J, et al. Among authors: yan f. Front Cell Neurosci. 2018 Aug 30;12:283. doi: 10.3389/fncel.2018.00283. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30233322 Free PMC article.

10

Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.

Ni J, Yan F, Qin W, Yu L, Zhang G, Liu F, Yang X, Yang B, Hao C, Wang T, Liu P, Yuan J, Wu G. Ni J, et al. Among authors: yan f. Sci Rep. 2019 Oct 4;9(1):14337. doi: 10.1038/s41598-019-49814-6. Sci Rep. 2019. PMID: 31586081 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,750 results

Search Page

Filters